Therefore, the present study focused on the regulation of the PI3K/AKT signaling pathway and macrophage polarization by SORBS1 to inhibit EMT in breast cancer, with the aim of discovering potential drug targets for the clinical treatment of this disease. Here, SORBS1 is linked to breast carcinoma.